GLIS; Sarcopenia; Standardization; Terminology; Humans; Terminology as Topic; Muscle Strength; Gerontology; Geriatrics and Gerontology; Automotive Engineering
Abstract :
[en] ("[en] METHODS: The aim of this paper is to define terms commonly related to sarcopenia to enable standardization of these terms in research and clinical settings. The Global Leadership Initiative in Sarcopenia (GLIS) aims to bring together leading investigators in sarcopenia research to develop a single definition that can be utilized worldwide; work on a global definition of sarcopenia is ongoing. The first step of GLIS is to develop the common terminology, or a glossary, that will facilitate agreement on a global definition of sarcopenia as well as interpretation of clinical and research findings.
RESULTS: Several terms that are commonly used in sarcopenia research are defined, including self-reported measures of function and ability; objective physical performance tests; and measures related to muscle function and size.
CONCLUSION: As new methods and technologies are developed, these definitions may be expanded or refined over time. Our goal is to promote this common language to describe sarcopenia and its components in clinical and research settings in order to increase clinical awareness and research interest in this important condition. We hope that the use of common terminology in sarcopenia research will increase understanding of the concept and improve communication around this important age-related condition.","[en] ","")
Disciplines :
Public health, health care sciences & services
Author, co-author :
Cawthon, Peggy M ; California Pacific Medical Center, Research Institute, 550 16th Street, Second Floor, San Francisco, CA, 94143, USA ; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
Visser, Marjolein; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. m.visser@vu.nl ; The Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. m.visser@vu.nl
Arai, Hidenori; National Center for Geriatrics and Gerontology, Obu, Aichi, Japan
Ávila-Funes, José A; Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Barazzoni, Rocco; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy
Bhasin, Shalender; Bostin Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Binder, Ellen; Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis, MO, USA ; Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St. Louis, MO, USA
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cederholm, Tommy; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden ; Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden
Chen, Liang-Kung; Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan ; Center for Geriatrics and Gerontology, Taipei Veterans Generfranal Hospital, Taipei, Taiwan ; Taipei Municipal Gan-Dau Hospital (Managed by Taipei Veterans General Hospital), Taipei, Taiwan
Cooper, Cyrus ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé ; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK ; Department of Epidemiology, University of Oxford, Oxford, OX, UK
Duque, Gustavo; Research Institute of the McGill University Health Centre, Montreal, QC, Canada ; Division of Geriatric Medicine, Department of Medicine, McGill University, Montreal, QC, Canada
Fielding, Roger ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé ; Nutrition Exercise, Physiology, and Sarcopenia Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center On Aging, Tufts University, Boston, MA, USA
Guralnik, Jack; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
Kiel, Douglas P; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
Kirk, Ben; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC, Australia ; Department of Medicine-Western Health, The University of Melbourne, St. Albans, VIC, Australia
Sayer, Avan A; AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Faculty of Medical Sciences, Newcastle University, Newcastle, UK
Von Haehling, Stephan; Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany ; German Centre for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany
Woo, Jean; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China ; Faculty of Medicine, Centre for Nutritional Studies, The Chinese University of Hong Kong, Hong Kong, China
Cruz-Jentoft, Alfonso J; Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
Dr. Cruz-Jentoft reports obtaining research funding from AstraZeneca. Dr. Kirk reports consultancy/honorarium fees from the following companies/enterprises that work in the medical and/or musculoskeletal fields: Abbott Nutrition (UK); Academy of Nutrition and Dietetics (USA); AusDoc (Australian Doctor). Dr. Kirk is also supported by a research grant from TSI Pharmaceuticals. Dr. Kiel reports royalties from publication Wolters Kluwer for chapters in UpToDate on Falls; scientific advisory boards for Pfizer, Solarea Bio, Reneo; grants from Amgen and Solarea Bio; Data Safety and Safety Monitoring Board for Agnovos. Dr. Landi reports consultancy and invited lecture to Abbott, Nutricia, ErreKappa, and Professional Dietetics. Dr. Duque reports paid consultancy for TSI, Abbott, and Nutricia. Dr. Bruyère reports to being a shareholder of SARQOL SRL. Dr. Cawthon reports being a consultant to BioAge Labs. Dr. Fielding reports to being a paid consultant for Pfizer, Nestle, Amazentis, Biophytis, Rejuvenate Biomed, Juvicell. Dr. Fielding reports to being on the advisory Board for Inside Tracker and Cytokinetics and reports to being a shareholder of Azcella Health. He has obtained research funding from Lonza. Dr. Bhasin reports consultancy fees from OPKO Health and Aditum Bio. He has obtained research funding from AbbVie and Metro International BioTech. Dr. Von Haehling reports being a paid consultant for and/or received honoraria payments from AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Chugai, Grünenthal, Helsinn, Hexal, Novartis, Pharmacosmos, Respicardia, Roche, Servier, Sorin, and Vifor. Dr. Cederholm reports providing paid lectures arranged by medical nutrition companies. Dr. Binder reports consulting income from Eisai, Inc. Drs. Sayer, Cooper, Arai, Guralnik, Woo, Ávila-Funes, Chen, Visser, Barazzoni report no current personal financial interests.
Evans WJ, Campbell WW (1993) Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 123(2 Suppl):465–468 DOI: 10.1093/jn/123.suppl_2.465
Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763 DOI: 10.1093/oxfordjournals.aje.a009520
Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256 DOI: 10.1016/j.jamda.2011.01.003
Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558 DOI: 10.1093/gerona/glu010
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39(4):412–423 DOI: 10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(4):601
Morley JE, Abbatecola AM, Argiles JM et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12(6):403–409 DOI: 10.1016/j.jamda.2011.04.014
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36 DOI: 10.1002/jcsm.12048
Verbrugge LM, Jette AM (1994) The disablement process. Soc Sci Med (1982) 38(1):1–14 DOI: 10.1016/0277-9536(94)90294-1
Nagi SZ (1979) The concept and measurement of disability. In: Berkowitz ED (ed) Disability policies and government programs. Praeger, New York, p I–15
Nagi SZ (1965) Some conceptual issues in disability and rehabilitation. In: Sussman MB (ed) Sociology and rehabilitation. American Sociological Association, Washington, D.C., p 13 (IO&l)
Nagi SZ (1991) Disability concepts revisited: implications for prevention. In: Pope AM, Tarlov AR, Division of Health Promotion and Disease Prevention IoM (eds) Disability in America: toward a National Agenda for prevention. National Academy Press, Washington, D.C., pp 309–327
International Classification of Impairments (1980) Disabilities, and handicaps. World Health Organization, Geneva, p 1980
Veronese N, Honvo G, Amuthavalli Thiyagarajan J et al (2022) Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report. Aging Clin Exp Res 34(3):481–483 DOI: 10.1007/s40520-022-02080-5
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61–65
Cress ME, Schechtman KB, Mulrow CD, Fiatarone MA, Gerety MB, Buchner DM (1995) Relationship between physical performance and self-perceived physical function. J Am Geriatr Soc 43(2):93–101 DOI: 10.1111/j.1532-5415.1995.tb06372.x
Lange-Maia BS, Karvonen-Gutierrez CA, Strotmeyer ES et al (2019) Factors influencing longitudinal stair climb performance from Midlife to Early Late life: the study of women’s health across the Nation Chicago and Michigan sites. J Nutr Health Aging 23(9):821–828 DOI: 10.1007/s12603-019-1254-2
Dite W, Temple VA (2002) A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil 83(11):1566–1571 DOI: 10.1053/apmr.2002.35469
Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332(9):556–561 DOI: 10.1056/NEJM199503023320902
Fielding RA, Rejeski WJ, Blair S et al (2011) The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci 66(11):1226–1237 DOI: 10.1093/gerona/glr123
Jyväkorpi SK, Ramel A, Strandberg TE et al (2021) The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans. Eur Geriatr Med 12(2):303–312 DOI: 10.1007/s41999-020-00438-4
Blackwell T, Cawthon PM, Marshall LM, Brand R (2009) Consistency of leg extension power assessments in older men: the Osteoporotic Fractures in Men (MrOS) study. Am J Phys Med Rehabil 88(11):934–940 DOI: 10.1097/PHM.0b013e3181bbddfb
Strotmeyer ES, Winger ME, Cauley JA et al (2018) Normative values of muscle power using force plate jump tests in men aged 77–101 years: the Osteoporotic Fractures in Men (MrOS) study. J Nutr Health Aging 22(10):1167–1175 DOI: 10.1007/s12603-018-1081-x
Bosco C, Luhtanen P, Komi PV (1983) A simple method for measurement of mechanical power in jumping. Eur J Appl Physiol Occup Physiol 50(2):273–282 DOI: 10.1007/BF00422166
Linge J, Heymsfield SB, Dahlqvist Leinhard O (2019) On the Definition of Sarcopenia in the Presence of Aging and Obesity-Initial Results from UK Biobank. J Gerontol Ser A Biol Sci Med Sci 75(7):1309–1316
Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064 DOI: 10.1093/gerona/61.10.1059
Linge J, Petersson M, Forsgren MF, Sanyal AJ, Dahlqvist Leinhard O (2021) Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study. J Cachexia Sarcopenia Muscle 12(6):1513–1526
Perkisas S, Bastijns S, Baudry S et al (2021) Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. Eur Geriatr Med 12(1):45–59 DOI: 10.1007/s41999-020-00433-9
Perkisas S, Baudry S, Bauer J et al (2019) The SARCUS project: evidence-based muscle assessment through ultrasound. Eur Geriatr Med 10(1):157–158 DOI: 10.1007/s41999-018-0141-4
Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89(1):104–110 DOI: 10.1152/jappl.2000.89.1.104
